MedPath

Korea Otsuka Pharmaceutical Co., Ltd.

🇰🇷South Korea
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.otsuka.co.kr

Clinical Trials

42

Active:1
Completed:32

Trial Phases

4 Phases

Phase 1:7
Phase 2:3
Phase 3:8
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (30 trials with phase data)• Click on a phase to view related trials

Phase 4
12 (40.0%)
Phase 3
8 (26.7%)
Phase 1
7 (23.3%)
Phase 2
3 (10.0%)

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Not yet recruiting
Conditions
Tuberculosis, Multidrug-Resistant
Interventions
First Posted Date
2024-11-05
Last Posted Date
2024-11-05
Lead Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Target Recruit Count
222
Registration Number
NCT06674291

Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab.

Recruiting
Conditions
Chronic Gastritis
Acute Gastritis
First Posted Date
2021-09-17
Last Posted Date
2023-09-28
Lead Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Target Recruit Count
600
Registration Number
NCT05048069
Locations
🇰🇷

Soon Chun Hyang University Hospital Seoul, Seoul, Korea, Republic of

A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis

Phase 3
Completed
Conditions
Acute Gastritis
Chronic Gastritis
Interventions
Drug: MCT-SR
First Posted Date
2019-12-06
Last Posted Date
2021-03-11
Lead Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Target Recruit Count
392
Registration Number
NCT04189705
Locations
🇰🇷

Chung-Ang University Hospital, Seoul, Korea, Republic of

To Evaluate Pharmacokinetics and Safety of Two Different Formulation of Rebamipide in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
First Posted Date
2019-11-04
Last Posted Date
2019-11-04
Lead Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Target Recruit Count
40
Registration Number
NCT04150172
Locations
🇰🇷

CHA Bundang Medical Center, CHA University, Seongnam, Gyeonggi-do, Korea, Republic of

To Evaluate Food Effect on the Pharmacokinetics of Rebamipide in Healthy Volunteers

First Posted Date
2019-11-04
Last Posted Date
2019-11-04
Lead Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Target Recruit Count
24
Registration Number
NCT04150146
Locations
🇰🇷

CHA Bundang Medical Center, CHA University, Bundang, Gyeonggi-do, Korea, Republic of

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath